244 related articles for article (PubMed ID: 34603487)
21. Bioinformatics Analysis Reveals Distinct Molecular Characteristics of Hepatitis B-Related Hepatocellular Carcinomas from Very Early to Advanced Barcelona Clinic Liver Cancer Stages.
Kong FY; Wei X; Zhou K; Hu W; Kou YB; You HJ; Liu XM; Zheng KY; Tang RX
PLoS One; 2016; 11(7):e0158286. PubMed ID: 27454179
[TBL] [Abstract][Full Text] [Related]
22. Identifying hepatocellular carcinoma-related hub genes by bioinformatics analysis and CYP2C8 is a potential prognostic biomarker.
Li C; Zhou D; Jiang X; Liu M; Tang H; Mei Z
Gene; 2019 May; 698():9-18. PubMed ID: 30825595
[TBL] [Abstract][Full Text] [Related]
23. Identification of Biomarkers Based on Bioinformatics Analysis: The Expression of Ubiquitin-Conjugating Enzyme E2T (UBE2T) in the Carcinogenesis and Progression of Hepatocellular Carcinoma.
Zhao X; Weng W; Jin M; Li S; Chen Q; Li B; Zhou Z; Lan C; Yang Y
Med Sci Monit; 2021 Mar; 27():e929023. PubMed ID: 33658475
[TBL] [Abstract][Full Text] [Related]
24. Integrative analysis identifies key mRNA biomarkers for diagnosis, prognosis, and therapeutic targets of HCV-associated hepatocellular carcinoma.
Zhang Y; Tang Y; Guo C; Li G
Aging (Albany NY); 2021 May; 13(9):12865-12895. PubMed ID: 33946043
[TBL] [Abstract][Full Text] [Related]
25. Identification of Hepatocellular Carcinoma-Related Potential Genes and Pathways Through Bioinformatic-Based Analyses.
Wan Z; Zhang X; Luo Y; Zhao B
Genet Test Mol Biomarkers; 2019 Nov; 23(11):766-777. PubMed ID: 31633428
[No Abstract] [Full Text] [Related]
26. Identification and validation of three core genes in p53 signaling pathway in hepatitis B virus-related hepatocellular carcinoma.
Yu M; Xu W; Jie Y; Pang J; Huang S; Cao J; Gong J; Li X; Chong Y
World J Surg Oncol; 2021 Mar; 19(1):66. PubMed ID: 33685467
[TBL] [Abstract][Full Text] [Related]
27. The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data.
Zhang C; Peng L; Zhang Y; Liu Z; Li W; Chen S; Li G
Med Oncol; 2017 Jun; 34(6):101. PubMed ID: 28432618
[TBL] [Abstract][Full Text] [Related]
28. Identification and Analysis of Potential Key Genes Associated With Hepatocellular Carcinoma Based on Integrated Bioinformatics Methods.
Li Z; Lin Y; Cheng B; Zhang Q; Cai Y
Front Genet; 2021; 12():571231. PubMed ID: 33767726
[TBL] [Abstract][Full Text] [Related]
29. Expression of the Long Intergenic Non-Protein Coding RNA 665 (LINC00665) Gene and the Cell Cycle in Hepatocellular Carcinoma Using The Cancer Genome Atlas, the Gene Expression Omnibus, and Quantitative Real-Time Polymerase Chain Reaction.
Wen DY; Lin P; Pang YY; Chen G; He Y; Dang YW; Yang H
Med Sci Monit; 2018 May; 24():2786-2808. PubMed ID: 29728556
[TBL] [Abstract][Full Text] [Related]
30. Exploring new targets for the treatment of hepatitis-B virus and hepatitis-B virus-associated hepatocellular carcinoma: A new perspective in bioinformatics.
Wang Y; Wang S; Che Y; Chen D; Liu Y; Shi Y
Medicine (Baltimore); 2021 Aug; 100(33):e26917. PubMed ID: 34414947
[TBL] [Abstract][Full Text] [Related]
31. Screening of significant biomarkers with poor prognosis in hepatocellular carcinoma via bioinformatics analysis.
Sun Q; Liu P; Long B; Zhu Y; Liu T
Medicine (Baltimore); 2020 Aug; 99(32):e21702. PubMed ID: 32769939
[TBL] [Abstract][Full Text] [Related]
32. Identification of potential hub genes related to the progression and prognosis of hepatocellular carcinoma through integrated bioinformatics analysis.
Song X; Du R; Gui H; Zhou M; Zhong W; Mao C; Ma J
Oncol Rep; 2020 Jan; 43(1):133-146. PubMed ID: 31746405
[TBL] [Abstract][Full Text] [Related]
33. Identification of hub genes associated with prognosis, diagnosis, immune infiltration and therapeutic drug in liver cancer by integrated analysis.
Lei X; Zhang M; Guan B; Chen Q; Dong Z; Wang C
Hum Genomics; 2021 Jun; 15(1):39. PubMed ID: 34187556
[TBL] [Abstract][Full Text] [Related]
34. Identification of hub genes for early detection of bone metastasis in breast cancer.
Zhao Z; Yang H; Ji G; Su S; Fan Y; Wang M; Gu S
Front Endocrinol (Lausanne); 2022; 13():1018639. PubMed ID: 36246872
[TBL] [Abstract][Full Text] [Related]
35. Identification and validation of real hub genes in hepatocellular carcinoma based on weighted gene co-expression network analysis.
Qiao Y; Yuan F; Wang X; Hu J; Mao Y; Zhao Z
Cancer Biomark; 2022; 35(2):227-243. PubMed ID: 36120772
[TBL] [Abstract][Full Text] [Related]
36. Identification of potential hub genes associated with the pathogenesis and prognosis of hepatocellular carcinoma via integrated bioinformatics analysis.
Meng Z; Wu J; Liu X; Zhou W; Ni M; Liu S; Guo S; Jia S; Zhang J
J Int Med Res; 2020 Jul; 48(7):300060520910019. PubMed ID: 32722976
[TBL] [Abstract][Full Text] [Related]
37. Identification of Differentially Expressed Genes Associated with the Prognosis and Diagnosis of Hepatocellular Carcinoma by Integrated Bioinformatics Analysis.
Kakar MU; Mehboob MZ; Akram M; Shah M; Shakir Y; Ijaz HW; Aziz U; Ullah Z; Ahmad S; Ali S; Yin Y
Biomed Res Int; 2022; 2022():4237633. PubMed ID: 36317111
[TBL] [Abstract][Full Text] [Related]
38. Identification of Key Biological Processes, Pathways, Networks, and Genes with Potential Prognostic Values in Hepatocellular Carcinoma Using a Bioinformatics Approach.
Lu H; Zhu Q
Cancer Biother Radiopharm; 2021 Dec; 36(10):837-849. PubMed ID: 32598174
[No Abstract] [Full Text] [Related]
39. Screening and Identification of Key Biomarkers in Inflammatory Breast Cancer Through Integrated Bioinformatic Analyses.
Wu J; Lv Q; Huang H; Zhu M; Meng D
Genet Test Mol Biomarkers; 2020 Aug; 24(8):484-491. PubMed ID: 32598242
[No Abstract] [Full Text] [Related]
40. Identification and Integrated Analysis of Key Biomarkers for Diagnosis and Prognosis of Non-Small Cell Lung Cancer.
Liu X; Liu X; Li J; Ren F
Med Sci Monit; 2019 Dec; 25():9280-9289. PubMed ID: 31805030
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
